| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Soland Daniel B is a Director at ACADIA PHARMACEUTICALS INC with holdings across 3 companies. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | DBVT Dbv Technologies S.A. | Director | Buy | 15,000 | $1.62 | $24,300.00 | +300.0% | -34.8% | -69.9% | |
| Sep 27, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Director | Buy | 10,000 | $11.87 | $118,749.99 | +490.7% | - | - | |
| Mar 2, 2018 | ACAD Acadia Pharmaceuticals Inc | Director | Buy | 10,000 | $23.49 | $234,910.00 | +71.4% | - | - |